Effect of HFE variants on sphingolipid expression by SH-SY5Y human neuroblastoma cells

Neurochemical Research

Volumn 36, Issue 9, 2011, Pages 1687-1696

  Ali Rahmani, F ^a   Hengst, J A ^a   Connor, J R ^a   Schengrund, C L ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

C282Y HFE; H63D HFE; Hemochromatosis protein HFE; SH SY5Y human neuroblastoma cells; Sphingolipids; Sphingosine kinase 1

Indexed keywords

CHOLERA TOXIN; GANGLIOSIDE; HFE PROTEIN; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIPID RAFT; LIPOGENESIS; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPHINGOLIPID SYNTHESIS;

ALLELES; ANIMALS; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; POINT MUTATION; SPHINGOLIPIDS;

EID: 80755163525     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0403-8     Document Type: Article

References (54)

1. Goswami T, Andrews NC (2006) Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 281:28494-28498 (Pubitemid 44506991)
2. Combarros O, Garcia-Roman M, Fontalba A et al (2003) Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease. Dement Geriatr Cogn Disord 15:151-154 (Pubitemid 36206644)
3. Connor JR, Lee SY (2006) HFE mutations and Alzheimer's disease. J Alzheimers Dis 10:267-276 (Pubitemid 44763997)
4. Osborne NJ, Gurrin LC, Allen KJ et al (2010) HFE C282Y homozygotes are at increased risk of breast and colorectal cancer. Hepatology 51:1311-1318
5. Correia AP, Pinto JP, Dias V et al (2009) CAT53 and HFE alleles in Alzheimer's disease: A putative protective role of the C282Y HFE mutation. Neurosci Lett 457:129-132
6. Waheed A, Parkkila S, Zhou XY et al (1997) Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc. Natl. Acad. Sci. USA 94:12384-12389
7. Lawless MW, Mankan AK, White M et al (2007) Expression of hereditary hemochromatosis C282Y HFE protein in HEK293 cells activates specific endoplasmic reticulum stress responses. BMC Cell Biol 8:30
8. Feder JN, Penny DM, Irrinki A et al (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 95:1472-1477 (Pubitemid 28103416)
9. Calzolari A, Raggi C, Deaglio S et al (2006) TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. J Cell Sci 119: 4486-4498 (Pubitemid 44830648)
10. Chen J, Chloupkova M, Gao J et al (2007) HFE modulates transferrin receptor 2 levels in hepatoma cells via interations that differ from transferrin receptor 1-HFE interactions. J Biol Chem 282:36862-36870
11. Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387:569-572 (Pubitemid 27248754)
12. Sakiyama H, Robbins PW (1973) Glycolipid synthesis and tumorigenicity of clones isolated from the Nil 2 line of hamster embryo fibroblasts. Fed Proc 32:86-90
13. Brady RO, Fishman PH, Mora PT (1973) Membrane components and enzymes in virally transformed cells. Fed Proc 32:102-108
14. Hakomori S (1981) Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Ann Rev Biochem 50:733-764
15. Petro KA, Schengrund C-L (2009) Membrane raft disruption promotes axonogenesis in N2a neuroblastoma cells. Neurochem Res 34:29-37
16. Ruckhaberle E, Karn T, Rody A et al (2009) Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer. J Cancer Res Clin Oncol 135:1005-1013
17. Fantini J, Barrantes FJ (2009) Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim Biophys Acta 1788:2345-2361
18. Miyagi T, Wada T, Yamaguchi K et al (2008) Plasma membraneassociated sialidase as a crucial regulator of transmembrane signalling. J Biochem 144:279-285
19. Allende ML, Proia RL (2002) Lubricating cell signaling pathways with gangliosides. Curr Opin Struct Biol 12:587-592 (Pubitemid 35449065)
20. Yamamoto N, Hirabayashi Y, Amari M et al (2005) Assembly of hereditary amyloid beta-protein variants in the presence of favorable gangliosides. FEBS Lett 579:2185-2190 (Pubitemid 40469690)
21. Yamamoto N, Matsuzaki K, Yanagisawa K (2005) Cross-seeding of wild-type and hereditary variant-type amyloid beta-proteins in the presence of gangliosides. J Neurochem 95:1167-1176 (Pubitemid 41713499)
22. Yanagisawa M, Ariga T, Yu RK (2010) Cytotoxic effects of G(M1) ganglioside and amyloid beta-peptide on mouse embryonic neural stem cells. ASN Neuro 2:e00029
23. Tamboli IY et al (2005) Inhibition of glycosphingolipid biosynthesis reduces secretion of the β-amyloid precursor protein and amyloid β-peptide. J Biol Chem 280:28110-28117 (Pubitemid 41076929)
24. Cecchi C, Nichino D, Zampagni M et al (2009) A protective role for lipid raft cholesterol against amyloid-induced membrane damage in human neuroblastoma cells. Biochim Biophys Acta 1788:2204-2216
25. Wang XS, Lee S, Simmons Z et al (2004) Increased incidence of the HFE mutation in amyotropic lateral sclerosis and related cellular consequences. J Neural Sci 227:27-33 (Pubitemid 39491122)
26. Lee SY, Patton SM, Henderson RJ et al (2007) Consequences of expressing mutants of the hemochromatosis gene (HFE) into a human neuronal cell line lacking endogenous HFE. FASEB J 21:564-576 (Pubitemid 46213503)
27. Petro KA, Dyer MA, Yowler BC et al (2006) Disruption of lipid rafts enhances activity of botulinum neurotoxin serotype A. Toxicon 48:1035-1045 (Pubitemid 44767921)
28. Kasperzyk JL, d'Azzo A, Platt FM et al (2005) Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice. J Lipid Res 46:744-751 (Pubitemid 43073284)
29. Svennerholm L (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys Acta 24:604-611
30. Suetake K, Yu RK (2003) Thin-layer chromatography; immunostaining of glycolipid antigens; and interpretation of falsepositive findings with acidic lipids. Methods Enzymol 363: 312-319 (Pubitemid 37267679)
31. Hengst JA, Guilford JM, Conroy EJ et al (2010) Enhancement of sphingosine kinase 1 catalytic activity by deletion of 21 amino acids from the COOH-terminus. Arch Biochem Biophys 494:23-31
32. Hengst JA, Guilford JM, Fox TE et al (2009) Sphingosine kinase 1 localized to the plasma membrane lipid raft microdomain overcomes serum deprivation induced growth inhibition. Arch Biochem Biophys 492:62-73
33. Bickel PE, Scherer PE, Schnitzer JE et al (1997) Flotillin and epidermal surface antigen define a new family of caveolaeassociated integral membrane proteins. J Biol Chem 272:13793-13802 (Pubitemid 27225457)
34. Johnstone SR, Stallcup WB (1988) Altered expression of D1.1 ganglioside in the cerebellum of the Weaver mouse. J Neurochem 51:1655-1657 (Pubitemid 18264392)
35. Purpura DP, Baker HJ (1978) Meganeurites and other aberrant processes of neurons in feline GM1-gangliosidosis: A Golgi study. Brain Res 116:1-21
36. Yanagisawa M, Ariga T, Yu RK (2006) Cholera toxin B subunit binding does not correlate with GM1 expression: A study using mouse embryonic neural precursor cells. Glycobiology 16:19G- 22G (Pubitemid 44390920)
37. Cuvillier O, Ader I, Bouquerel P et al (2010) Activation of sphingosine kinase-1 in cancer: Implications for therapeutic targeting. Curr Mol Pharmacol 3:53-65
38. Duchemin AM, Ren Q, Neff NH et al (2008) GM1-induced activation of phosphatidylinositol 3-kinase: Involvement of Trk receptors. J Neurochem 104:1466-1477 (Pubitemid 351316760)
39. Kwak DH, Yu K, Kim SM et al (2006) Dynamic changes of gangliosides expression during the differentiation of embryonic and mesenchymal stem cells into neural cells. Exp Mol Med 38:668-676 (Pubitemid 46103589)
40. Wu G, Xie X, Lu ZH et al (2009) Sodiium-calcium exchanger complexed with GM1 ganglioside in nuclear membrane transfers calcium from nucleoplasm to endoplasmic reticulum. Proc Natl Acad Sci USA 106:10829-10834
41. Rosner H (1982) Ganglioside changes in the chicken optic lobes as biochemical indicators of brain development and maturation. Brain Res 236:49-61
42. Kabayama K, Sato T, Saito K et al (2007) Dissociationof the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc Natl Acad Sci USA 104: 13678-13683 (Pubitemid 350003380)
43. Van Brocklyn J, Bremer EG, Yates AJ (1993) Gangliosides inhibit platelet-derived growth factor-stimulated receptor dimerization in human glioma U-1242MG and Swiss 3T3 cells. J Neurochem 61:371-374 (Pubitemid 23175927)
44. Mutoh T, Tokuda A, Miyadai T (1995) Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc Natl Acad Sci USA 92:5087-5091
45. Rusnati M, Urbinati C, Tanghetti E et al (2002) Cell membrane ganglioside GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2. Proc Natl Acad Sci USA 99: 4367-4372 (Pubitemid 34285991)
46. Kuziemko GM, Stroh M, Stevens RC (1996) Cholera toxin binding affinity and specificity for gangliosides determined by surface Plasmon resonance. Biochemistry 35:6375-6384 (Pubitemid 26164071)
47. Van Brocklyn JR, Jackson CA, Pearl DK et al (2005) Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: Roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J Neuropathol Exp Neurol 64:695-705 (Pubitemid 41177111)
48. Ruckhaberle E, Rody A, Engels K et al (2008) Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat 112:41-52
49. Brizuela L, Dayon A, Doumerc N et al (2010) The sphingosine kinase-1 survival pathway is a molecular target for the tumorsuppressive tea and wine polyphenols in prostate cancer. FASEB J 24:3882-3894
50. Lee SY, Liu S, Mitchell RM et al (2010) HFE polymorphisms influence the response to chemotherapeutic agents via induction of p16INK4A. Int J Cancer. doi:10.1002/ijc.25888
51. Chumanevich AA, Poudyal D, Cui X et al (2010) Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase. Carcinogenesis 31:1787-1793
52. Kapitonov D, Allegood JC, Mitchell C et al (2009) Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts. Cancer Res 69:6915-6923
53. Madhankumar AB, Slagle-Webb B, Wang X et al (2009) Efficacy of IL-13 receptor targeted liposomal doxorubicin in the intracranial brain tumor model. Mol Cancer Ther 8:648-654
54. Svennerholm L (1980) Ganglioside designation. Adv Exp Med Biol 125:11